Public Private Partnership supports intestinal health in early life

Thema:
Metabolic and immune health
28 February 2023

TNO, Mead Johnson Greater China, Adare Pharmaceuticals SAS and Schothorst Feed Research started a public private partnership. Project Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.

Early life nutrition

Early life nutrition is of vital importance for the gut and overall health in humans and animals. During this vulnerable period, the foundations of lifelong immune homeostasis and microbial colonisation, especially in the gastrointestinal tract, are established. Risk reduction measures or optimised diets during these early stages of life may be most effective and efficient for improving health, increasing quality of life, and lowering costs to society due to gut/immune-related diseases and disorders. However, there is room for improvement of the gut in early life and consequently overall health. This is what this partnership contributes to.

About project Fontanelle

1. Integrates in vitro and ex vivo model platforms

The partnership will address this window of opportunity through advanced integration of in vitro and ex vivo model platforms of the early life gastrointestinal tract, representing the main pillars of gut health:

  • gut physiology (incl. intestinal barrier function),
  • gut microbiome
  • gut-associated lymphoid tissue (GALT) immune response.

The InTESTine™ and iScreen platform technologies, using fresh and early life gut tissue explants or infant microbial communities, respectively, will be adapted for the early life environment and used to study the effect of nutrients and bacteria on early life gut health.

2. Gut health space model: Apply Artificial Intelligence modelling to evaluate immune effects

Next, the project will apply predictive artificial intelligence (AI) modelling to evaluate potential systemic and local immune effects, using the outcomes of the in vitro and ex vivo model platforms. Moreover, all data will be integrated and subjected to state-of-the-art statistical analyses to generate a visualisation tool, the so called ‘gut health space model’, allowing to evaluate and visualise the gut health enhancing effects of early life nutrition.

This project will hence set-up a (prototype of a) novel integrated early life-specific in vitro, ex vivo and AI workflow to test and evaluate the potential health benefits of early life nutrition for infants and piglets and facilitate screening of solutions that contribute to long-lasting effects on gut health and overall well-being.

Do you want to learn more about this project? Contact Nicolette Pouw Duin

Get inspired

7 resultaten, getoond 1 t/m 5

Ancora Health develops personal diabetes plan with 360 methodology

Informatietype:
Insight
11 May 2023

With the help of TNO's knowledge of diabetic typing, Ancora Health wants to implement a diabetes lifestyle programme within healthcare.

MixMasters uses TNO phenotype test to offer personalised nutrition

Informatietype:
Insight
11 May 2023

TNO is helping MixMasters answer the question 'How can we personalise while remaining user-friendly?' Moreover, during their collaboration, the idea for a new concept was born: FoodiYou.

Personalised Health: Take it personal

Informatietype:
Insight
17 April 2023

TNO helps companies develop scientifically based personalised health applications. Knowledge is translated into applications by using a systems approach, and personalised health is put into practice. An example of this is the collaboration with Gabriele Ronnett of Johnson & Johnson Consumer Health Company.

Personalised food conveniently delivered to your home

Informatietype:
Insight
23 January 2023

MixMasters develops, manufactures, and packages personalised health food and sports supplements. They try to bring healthy food to their customers in innovative ways and focus mainly on the sports and health industry.

TNO's view of 2030: 50% reduction in lifestyle-related diseases

Informatietype:
Insight
14 November 2022

We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.